Radiofrequency Ablation in Treating Patients With Liver Cancer and Cirrhosis

Completed · Not applicable

Conditions studied: Liver Cancer

In brief

RATIONALE: Radiofrequency ablation uses a high-frequency, electric current to kill tumor cells. CT-, MRI-, or ultrasound-guided radiofrequency ablation may be an effective treatment for liver cancer and cirrhosis. PURPOSE: This phase II trial is studying how well radiofrequency ablation works in treating patients with liver cancer and cirrhosis.

Key facts

Study ID
NCT00132041
Run by
American College of Radiology Imaging Network
People needed
51
Starts
2005-12-01
Expected to finish
2010-11-01
Last updated by the study team
2020-09-10

Who can join

Age: 18 and older, up to 120. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.